Associate Vice President, Early Scientific Assessment Lead @ Merck
Associate Vice President and Head, BD and L Early Assessment and MRL Alliance Management @ Merck
Karen Akinsanya's Education
Imperial College London
Doctor of Philosophy (Ph.D.) (Endocrine Physiology)
1989 - 1993
Queen Mary, U. of London
BSc (Biochemistry)
1986 - 1989
University College London, U. of London
Postdoctoral Fellow (Developmental Genetics)
1995 - 1997
Stanford University Graduate School of Business
Executive Education (Managing Teams for Innovation and Success)
2004 - 2004
Tufts University
Postgraduate Training (Clinical Pharmacology, Drug Development and Regulation)
2005 - 2005
Karen Akinsanya's Skills
Drug Discovery
Biomarkers
Clinical Research
Clinical Development
Clinical Pharmacology
Pharmacology
Drug Development
Oncology
CRO
Cell Biology
Karen Akinsanya's Summary
Karen Akinsanya, based in New York, NY, US, is currently a President, R and D - Therapeutics at Schrödinger, bringing experience from previous roles at Schrödinger, Nautilus Biotechnology, Imperial College Foundation and The Rockefeller University. Karen Akinsanya holds a 1989 - 1993 Doctor of Philosophy (Ph.D.) in Endocrine Physiology @ Imperial College London. With a robust skill set that includes Drug Discovery, Biomarkers, Clinical Research, Clinical Development, Clinical Pharmacology and more, Karen Akinsanya contributes valuable insights to the industry. Karen Akinsanya has 3 emails on RocketReach.